Shareholding for the Period Ended December 31, 2015
Suven Life Sciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2015. For more details, kindly Click here21-01-2016
21-01-2016
Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015
Suven Life Sciences Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2015, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.14-01-2016
Suven Inc is presenting at Biotech Showcase 2016 and participating in the 34th Annual J.P. Morgan Healthcare Conference during January 11th to 14th, 2016 at San Francisco
Suven Life Sciences Ltd has informed BSE regarding a press release dated January 11, 2016 titled "Suven Inc is presenting at Biotech Showcase 2016 and participating in the 34th Annual J.P. Morgan Healthcare Conference during January 11th to 14th, 2016 at San Francisco".11-01-2016
Suven Life Sciences gains on securing three product patents
The stock moved higher by 3% to Rs 269, bouncing back nearly 5% from its early morning low on the NSE.05-01-2016
Suven Life Sciences secures three (3) Product Patents in Canada, ARIPO and South Korea
Suven Life Sciences Ltd has informed BSE regarding a Press Release dated January 05, 2016, titled "Suven Life Sciences secures three (3) Product Patents in Canada, ARIPO and South Korea".05-01-2016
Suven Life rises on receiving product patents in Europe, Macau
The company has been granted a patent each by Europe and Macau for drug used to treat disorders associated with neurodegenerative diseases29-12-2015
Suven Life Sciences secures Two (2) Product Patents in Europe and Macau
Suven Life Sciences Ltd has submitted to BSE a copy of Press Release dated December 29, 2015 titled "Suven Life Sciences secures Two (2) Product Patents in Europe and Macau".29-12-2015
Suven Life Sciences jumps on securing 7 product patents
The company has secured 7 product patents across SE Asia and Europe23-12-2015
Suven Life Sciences secures 7 (seven) Product Patents for their NCE's in ARIPO, Europe, Hong Kong, Japan, Macau and South Korea
Suven Life Sciences Ltd has informed BSE regarding a Press Release dated December 23, 2015 titled "Suven Life Sciences secures 7 (seven) Product Patents for their NCE's in ARIPO, Europe, Hong Kong, Japan, Macau and South Korea".23-12-2015
Authorised KMPs to determine materiality of events/information
Suven Life Sciences Ltd has informed BSE regarding "Authorised Key Managerial Personnel to determine materiality of events/information".22-12-2015